🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21481Original Research

Functional characterization of Caspr2 in a mouse model of sciatic nerve injury

Liu Chenglong¹,Wei Shanwen¹,Zhou Liyu¹,Li Di¹,Zou Mingming¹,Ma Yanxia¹

Soochow University

Read Executive PreviewQuick FAQ
Functional characterization of Caspr2 in a mouse model of sciatic nerve injury
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1904, Issue 32 • pp. 100-112Citation:Liu Chenglong et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织工程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • • Caspr2 expression is significantly downregulated in dorsal root ganglion neurons following sciatic nerve injury, suggesting its involvement in the regenerative response. • Knockdown of Caspr2 via siRNA promotes axonal growth in cultured dorsal root ganglion neurons, indicating an inhibitory role in axonal regeneration. • Overexpression of Caspr2 suppresses axonal extension, further confirming its function as a negative regulator of axonal regeneration. • Caspr2 represents a potential therapeutic target for enhancing peripheral nerve regeneration by modulating intrinsic neuronal growth capacity.
Sponsored Research Highlight

Abstract

BACKGROUND: The intrinsic molecular mechanisms and regulatory networks of peripheral nervous system injury remain to be systematically analyzed. Caspr2, as a cell adhesion molecule specifically expressed on the surface of neuronal axons, plays an important role in the myelination of nerve fibers, but the dynamic regulatory mechanism of Caspr2 in peripheral nerve regeneration has not been clarified. OBJECTIVE: To focus on the functional characterization of Caspr2 in a sciatic nerve injury model, reveal the molecular mechanism by which Caspr2 regulates axonal regeneration of dorsal root ganglion neurons, and provide a new perspective for developing precise repair strategies for peripheral nerve injury. METHODS: An ICR mouse model of sciatic nerve crush injury was established. The transcriptional and protein expression characteristics of Caspr2 in dorsal root ganglion tissue were analyzed by qRT-PCR and western blot, and the expression of Caspr2 in dorsal root ganglion neurons was analyzed by immunofluorescence staining. An intervention model was constructed using primary dorsal root ganglion neuron culture system: Caspr2 siRNA negative control group, Caspr2 siRNA group; Caspr2 empty vector control group, Caspr2 overexpression group. Axonal regeneration dynamics were quantitatively evaluated by Tuj1 immunofluorescence staining and AxioVision image analysis system. RESULTS AND CONCLUSION: (1) Injury response characteristics: On day 3 after sciatic nerve injury, the mRNA and protein expression levels of Caspr2 in dorsal root ganglion tissue decreased, and further decreased on day 7 after injury. In addition, the expression of Caspr2 in dorsal root ganglion neurons also significantly decreased on day 7 after injury. (2) Loss-of-function effect: Caspr2 siRNA treatment significantly promoted neuronal axon growth. (3) Overexpression effect: Caspr2 overexpression significantly inhibited neuronal axon extension. These results indicate that Caspr2, as a key inhibitory factor in peripheral nerve regeneration, participates in the nerve repair process by bidirectionally regulating axonal regeneration ability.

1. Introduction

Peripheral nerve injury can affect motor, sensory, and autonomic functions, and chronic cases are more likely to progress to irreversible disabilities such as denervated muscle atrophy [1-4]. Although the peripheral nervous system possesses some repair capacity, complete functional recovery is extremely rare. Regulation of axonal regeneration ability is a key scientific issue in nerve repair. Adult mammalian peripheral nervous system neurons retain limited regenerative potential, but the molecular regulatory network has not been fully elucidated [5-6]. Current research focuses on two consensus mechanisms: inhibitory microenvironment barriers and the decline of intrinsic regenerative capacity in mature neurons [7-8]. Although microenvironmental regulation strategies have achieved staged progress, clinical translation results remain unsatisfactory [9-10]. In contrast, activating the intrinsic regenerative program of neurons through epigenetic regulation or transcriptional reprogramming shows better prospects, suggesting that enhancing the autonomous regenerative ability of neurons may be the key to breaking through the bottleneck of injury repair.

Studies have found that Caspr2 (Contactin-associated protein-like 2), a member of the neurexin superfamily, plays an important role in neuronal development, synaptic plasticity, and neural circuit function [11]. Caspr2 affects the development of the nervous system by regulating the axon diameter, myelin thickness, and intrinsic excitability of cortical neurons in the cerebral commissural fibers. In gene knockout mice, morphological abnormalities in these structures persist from embryonic to adult stages [12]. Caspr2 plays an important role from axonal guidance during development to synaptic plasticity and behavioral regulation in adulthood [13]. After Caspr2 gene knockout, the number of neurite branches decreases [14], suggesting that Caspr2 may play a role in axonal regeneration after peripheral nerve injury. This study aims to investigate the expression changes of Caspr2 in neurons after peripheral nerve injury and the effects of silencing or overexpressing Caspr2 on injured axonal regeneration, laying an important theoretical foundation for developing targeted Caspr2 strategies to promote peripheral nerve regeneration.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Liu Chenglong, Wei Shanwen, Zhou Liyu, Li Di, Zou Mingming, Ma Yanxia (2026). Functional characterization of Caspr2 in a mouse model of sciatic nerve injury. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21481
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What is the role of Caspr2 in peripheral nerve regeneration?

Caspr2 acts as a key inhibitory factor in peripheral nerve regeneration. Its expression decreases after sciatic nerve injury, and knockdown of Caspr2 promotes axonal growth, while overexpression inhibits axonal extension, indicating that Caspr2 negatively regulates axonal regeneration.

How was the sciatic nerve injury model established in this study?

The model was established by applying a 40 g/mm² pressure microvascular clip at 5 mm distal to the sciatic notch for (2.0±0.5) seconds under a stereomicroscope, targeting the sciatic nerve innervated by L4-L5 dorsal root ganglia.

What methods were used to assess Caspr2 expression?

Caspr2 expression was assessed using qRT-PCR and western blot for mRNA and protein levels in dorsal root ganglion tissue, and immunofluorescence staining for localization in dorsal root ganglion neurons.

What are the potential clinical implications of targeting Caspr2?

Targeting Caspr2 could enhance the intrinsic regenerative capacity of neurons, offering a novel therapeutic strategy for peripheral nerve injury. However, challenges include identifying specific signaling pathways and developing safe and effective delivery methods.

What is the significance of the study's findings?

The study identifies Caspr2 as a novel negative regulator of axonal regeneration, providing a potential molecular target for developing therapies to improve functional recovery after peripheral nerve injury.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF